Shuangshen Medical Reports 2020 Net Profit of RMB 6.38 Million, Up 33% Year-over-Year Driven by Higher Revenue and Lower Expenses

Source: Wabei.com

Wabei.com, April 2,Shuangshen Medical(831230) Recently released its 2020 annual report. During the reporting period, the company achieved operating revenue of RMB 30,083,360.88, a year-on-year increase of 15.01%; the net profit attributable to shareholders of the listed company was RMB 6,379,715.62, a year-on-year increase of 33.31%.

During the reporting period, the net cash flow from operating activities amounted to RMB 11,776,856.07. As of the end of 2020, the net assets attributable to shareholders of the listed company totaled RMB 74,741,416.19.

During the reporting period, the net profit was RMB 6,379,715.62, compared to RMB 4,785,547.75 in the same period of the previous year, representing a year-on-year increase of 33.31%. This was primarily due to an increase in revenue and a decrease in expenses, resulting in higher net profit.

Financial expenses during the period amounted to -54,690.57 yuan, compared to -24,571.39 yuan in the same period of the previous year. Investment income during the period was 318,496.78 yuan, compared to 347,682.20 yuan in the same period of the previous year, representing a year-on-year decrease of 8.39%.

According to data from Wabei.com, SHUANGSHEN is a high-tech enterprise engaged in the research and development, production, and sales of titanium and titanium alloy implantable medical devices for neurosurgery, oral (maxillofacial) surgery, and cardiothoracic surgery.